We’re ready for day 2 of the #HFpEFSummit listening in on sessions about exercise intolerance and the new and late breaking clinical trials!
Exciting day ahead!

Excited to hear updates on @janetweimd.bsky.social #NIH #R01 on myocardial steatosis in women with #CMD: defining the pathway to #HFpEF
#HFpEFSummit

We’re ready to start session 3: clinic insight into #HFpEF pathobiology with chairs Eugenio Cingolani and Flora Sam.

Kicking off the session with Nancy Sweitzer “Sex, Lies and HFpEF”
#HFpEFSummit

Session 2: #obesity and #cardiometabolic #HFpEF starting now at #HFpEFSummit with @hopkinsheart.bsky.social Dr. Virginia Hahn discussing single cell analysis of HFpEF.

Happening now! #HFpEFSummit
Dr. Traci Goodchild sharing data on their study showing the effects of #semaglutide on #HFpEF models.
#GLP1

Great talk #HFpEFSummit from @eduardomarban.bsky.social on a new therapy currently in development to treat #HFpEF.